Skye Bioscience Inc (SKYE)
0.76
+2.66%
Skye Bioscience Inc (SKYE) is currently trading at $0.76. This represents a gain of 2.66% from the previous session. With a market capitalization of $0.02B, SKYE is a key component of the Biotechnology sector. Investors looking to trade SKYE should compare margin rates and options platforms to optimize their portfolio management.
Broker Promotion
Get 15 Free Stocks on Moomoo →
T&Cs Apply. Trade SKYE commission-free.
Trading Platform Comparison
Moomoo
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Good for small traders
IBKR
- Min Deposit: $0
- Commissions: $0–$0.005/share
- Fractional Shares: ✅
- Options: ✅
- Notes: Professional-level tools
Ameritrade
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Strong research tools
Webull
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Easy mobile app
AI Market Sentiment
As of today, Skye Bioscience Inc (SKYE) shows a bullish trend. Analysts are watching the 0.79 level closely.
Fundamentals
Mkt Cap0.02B
P/E Ratio0.0000
Volume176,712
Others Watching (By Market Cap)
MGXMetagenomi Ther $1.55
+3.31% TVGN
Tevogen Bio Hol $0.29
+2.88% TVRD
Tvardi Therapeu $3.85
+2.81% JUNS
Jupiter Neurosc $0.58
-3.60%
60-Day Technical Chart
Advanced Charting
Need more indicators for SKYE? Use the world's #1 platform.
Open SKYE on TradingView →Charting Platforms
TradingView
Advanced charts & indicators, web & mobile
StockCharts
Technical analysis charts with overlays & indicators
BarCharts
Market data, charts, and technical signals
Finviz
Visual stock charts & heatmaps
Yahoo Finance Charts
Basic interactive charts with indicators
Side-by-Side: Stocks Near $1
| Metric |
SKYE +2.66% |
ALIT +0.87% |
BYND +10.46% |
DVLT +3.22% |
|---|---|---|---|---|
| Price | $0.76 | $0.77 | $0.80 | $0.72 |
| Mkt Cap | $0.02B | $0.40B | $0.36B | $0.42B |
| - | View → | View → | View → |
Latest Headlines
SKYE Stock Plunges 60% as Obesity Candidate Misses Key Phase II Goal
Yahoo Finance • Oct 7, 2025
Skye’s shares crash down to earth on Phase II obesity loss
Clinical Trials Arena • Oct 7, 2025
Skye shares crash as obesity drug falls short in key study
BioPharma Dive • Oct 6, 2025
Obesity drug combo keeps weight off: Skye study shows 22.3% loss
Stock Titan • Feb 2, 2026
$SKYE stock is down 56% today. Here's what we see in our data.
Quiver Quantitative • Oct 6, 2025
● Gemini Agentic AI Analyst Insight for SKYE
Market Education
- How to trade 0DTE $SPY options Sep 27, 2025
- How can Retail Traders not lose money to Institutional Traders Jul 15, 2023
- Stocks Pivot - Trending Up Dec 10, 2023
External Research